Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
ESMO Open|June 12, 2026
Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitusJ B Aragon-Ching, S Gupta, P Grivas, et al.
Bioresource Technology|January 15, 2013
Evaluation of growth, nutrient utilization and production of bioproducts by a wastewater-isolated microalgaDion M F Frampton, Robert H Gurney, Graeme A Dunstan, et al.
Oncology (Williston Park, N.Y.)|April 1, 1997
Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New ZealandJ F Bishop, J Dewar, G C Toner, et al.
Clinical Pharmacology and Therapeutics|April 22, 2011
Environmental and genetic factors affecting transport of imatinib by OATP1A2K Eechoute, R M Franke, W J Loos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancerJ F Bishop, J Dewar, G C Toner, et al.
Clinical Pharmacology and Therapeutics|May 15, 2007
Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotypeH Gurney, M Wong, R L Balleine, et al.
European Journal of Cancer Care|May 26, 2017
e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancerL E Heiniger, A B Smith, I Olver, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancerC N Sternberg, F Saad, J N Graff, et al.
British Journal of Cancer|July 14, 2011
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancerC K Lee, H Gurney, C Brown, et al.
British Journal of Cancer|August 22, 2014
Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancerK L Mahon, W Qu, J Devaney, et al.
Pageof 6